Literature DB >> 24841438

Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma.

Gaya Spolverato1, Aslam Ejaz, Yuhree Kim, Georgios C Sotiropoulos, Andreas Pau, Sorin Alexandrescu, Hugo Marques, Carlo Pulitano, Eduardo Barroso, Bryan M Clary, Luca Aldrighetti, Todd W Bauer, Dustin M Walters, Ryan Groeschl, T Clark Gamblin, Wallis Marsh, Kevin T Nguyen, Ryan Turley, Irinel Popescu, Catherine Hubert, Stephanie Meyer, Jean-Francois Gigot, Gilles Mentha, Timothy M Pawlik.   

Abstract

The association between tumor size and survival in patients with intrahepatic cholangiocarcinoma (ICC) undergoing surgical resection is controversial. We sought to define the incidence of major and microscopic vascular invasion relative to ICC tumor size, and identify predictors of microscopic vascular invasion in patients with ICC ≥5 cm. A total of 443 patients undergoing surgical resection for ICC between 1973 and 2011 at one of 11 participating institutions were identified. Clinical and pathologic data were evaluated using uni- and multivariate analyses. As tumor sized increased, the incidence of microscopic vascular invasion increased: <3 cm, 3.6 %; 3-5 cm, 24.7 %; 5-7 cm, 38.3 %; 7-15 cm, 32.9 %, ≥15 cm, 55.6 %; (p < 0.001). Increasing tumor size was also found to be associated with worsening tumor grade. The incidence of poorly differentiated tumors increased with increasing ICC tumor size: <3 cm, 9.7 %; 3-5 cm, 19.8 %; 5-7 cm, 24.2 %; 7-15 cm, 21.1 %; >15 cm, 31.6 % (p = 0.04). The presence of perineural invasion (odds ratio [OR] = 2.98) and regional lymph node metastasis (OR = 4.43) were independently associated with an increased risk of microscopic vascular invasion in tumors ≥5 cm (both p < 0.05). Risk of microscopic vascular invasion and worse tumor grade increased with tumor size. Large tumors likely harbor worse pathologic features; this information should be considered when determining therapy and prognosis of patients with large ICC.

Entities:  

Mesh:

Year:  2014        PMID: 24841438     DOI: 10.1007/s11605-014-2533-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

Review 1.  Multidisciplinary approaches to intrahepatic cholangiocarcinoma.

Authors:  Shishir K Maithel; T Clark Gamblin; Ihab Kamel; Celia Pamela Corona-Villalobos; Melanie Thomas; Timothy M Pawlik
Journal:  Cancer       Date:  2013-08-20       Impact factor: 6.860

2.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.

Authors:  Mechteld C de Jong; Hari Nathan; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; T Clark Gamblin; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Richard D Schulick; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-07-05       Impact factor: 44.544

3.  A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.

Authors:  T Okabayashi; J Yamamoto; T Kosuge; K Shimada; S Yamasaki; T Takayama; M Makuuchi
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

4.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

5.  Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.

Authors:  Akshat Saxena; Terence C Chua; Anik Sarkar; Francis Chu; David L Morris
Journal:  J Gastrointest Surg       Date:  2010-05-14       Impact factor: 3.452

6.  Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.

Authors:  Timothy M Pawlik; Keith A Delman; Jean-Nicolas Vauthey; David M Nagorney; Irene Oi-Lin Ng; Iwao Ikai; Yoshio Yamaoka; Jacques Belghiti; Gregory Y Lauwers; Ronnie T Poon; Eddie K Abdalla
Journal:  Liver Transpl       Date:  2005-09       Impact factor: 5.799

7.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

Review 8.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

9.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

10.  Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.

Authors:  S A Khan; M B Toledano; S D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

View more
  22 in total

1.  The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.

Authors:  Qing Chen; Liu-Xiao Yang; Xue-Dong Li; Dan Yin; Shi-Ming Shi; Er-Bao Chen; Lei Yu; Zheng-Jun Zhou; Shao-Lai Zhou; Ying-Hong Shi; Jia Fan; Jian Zhou; Zhi Dai
Journal:  Tumour Biol       Date:  2015-02-12

2.  Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases.

Authors:  Shin Hwang; Young-Joo Lee; Gi-Won Song; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-03-28       Impact factor: 3.452

3.  Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

4.  Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.

Authors:  Umberto Cillo; Gaya Spolverato; Alessandro Vitale; Aslam Ejaz; Sara Lonardi; David Cosgrove; Timothy M Pawlik
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

5.  Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.

Authors:  Feiling Feng; Xiaobing Wu; Xiaoliang Shi; Qingxiang Gao; Yue Wu; Yong Yu; Qingbao Cheng; Bin Li; Bin Yi; Chen Liu; Qing Hao; Lin Zhang; Chunfang Gao; Xiaoqing Jiang
Journal:  Int J Clin Oncol       Date:  2021-01-02       Impact factor: 3.402

6.  Prognostic Impact of Tumor Multinodularity in Intrahepatic Cholangiocarcinoma.

Authors:  Pietro Addeo; Issam Jedidi; Andrea Locicero; François Faitot; Constantin Oncioiu; Alina Onea; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2018-11-26       Impact factor: 3.452

7.  Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.

Authors:  Xu-Feng Zhang; Fabio Bagante; Jeffery Chakedis; Dimitrios Moris; Eliza W Beal; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

8.  Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.

Authors:  Gaya Spolverato; Yuhree Kim; Sorin Alexandrescu; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; T Clark Gamblin; John Miura; Shishir K Maithel; Malcolm H Squires; Carlo Pulitano; Charbel Sandroussi; Gilles Mentha; Todd W Bauer; Timothy Newhook; Feng Shen; George A Poultsides; J Wallis Marsh; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2014-10-30       Impact factor: 5.344

Review 9.  Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy.

Authors:  Michael K Turgeon; Shishir K Maithel
Journal:  Chin Clin Oncol       Date:  2019-09-02

10.  Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis.

Authors:  YiPing Chen; ShanGeng Weng
Journal:  J Gastrointest Surg       Date:  2020-11-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.